Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medacta GroupMEDGF 91 Market Cap is $3,439.7 Mil as of Jul. 17, 2026. GuruFocus rates MEDGF with a GF Score™ of 91/100 and a GF Value™ of $100.71. The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Medacta Group ranks better than 91.45% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medacta Group's share price for the quarter that ended in Dec. 2025 was $83.91. Medacta Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 19.9 Mil. Therefore, Medacta Group's market cap for the quarter that ended in Dec. 2025 was $1,670.7 Mil.
Medacta Group's quarterly market cap
increased
from Dec. 2024 ($1,671.4 Mil) to Jun. 2025 ($1,673.6 Mil) but then
declined
from Jun. 2025 ($1,673.6 Mil) to Dec. 2025 ($1,670.7 Mil).
Medacta Group's annual market cap
declined
from Dec. 2023 ($1,672.2 Mil) to Dec. 2024 ($1,671.4 Mil) and
declined
from Dec. 2024 ($1,671.4 Mil) to Dec. 2025 ($1,670.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medacta Group's Enterprise Value for Today is $3,698.9 Mil.
Medacta Group (OTCPK:MEDGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medacta Group Market Cap Related Terms
Medacta Group Market Cap Historical Data
* Premium members only.
The historical data trend for Medacta Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medacta Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medacta Group Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Medacta Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medacta Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medacta Group (MEDGF) has a Market Cap of $3,439.7 Mil as of Jul. 17, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medacta Group and its competitors. According to the industry distribution chart, Medacta Group ranks #74 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 8.5%.
Is Medacta Group's Market Cap too high?
Medacta Group's current Market Cap is $3,439.7 Mil. The Medical Devices & Instruments industry median Market Cap is 115.63. Medacta Group's value of $3,439.7 Mil is 2874.8% above this industry median. Based on the distribution chart, Medacta Group ranks #74 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medacta Group has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medacta Group ranks #74 out of 866 companies for Market Cap. This places Medacta Group in the top 9% of its industry — outperforming the majority of peers. The industry median Market Cap is 115.63. Medacta Group's value of $3,439.7 Mil is 2874.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medacta Group's current Market Cap of $3,439.7 Mil is 2874.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medacta Group and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medacta Group's current Market Cap is $3,439.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Medacta Group (MEDGF) has a current Market Cap of $3,439.7 Mil. The stock's GF Value™ is $100.71, compared to a current price of $83.91 — trading 16.7% below its estimated fair value. The current Market Cap is $3,439.7 Mil and 2874.8% above the Medical Devices & Instruments industry median of 115.63. Medacta Group's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medacta Group (MEDGF), the current Market Cap is $3,439.7 Mil as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medacta Group (MEDGF) Overvalued in 2026?
Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued.
The current stock price of $83.91 is trading 16.7% below its estimated GF Value™ of $100.71.
Key valuation signals for MEDGF:
Market Cap: $3,439.7 Mil
GF Value™: $100.71 vs. price of $83.91 (16.7% below fair value)
Industry Position: 2874.8% above the Medical Devices & Instruments median (#74 of 866)
No single metric tells the full story. See the MEDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
91GF Score
Get the complete analysis for MEDGF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDGF has been successfully added to your 
